Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company has primarily generated revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durability with treatment response, reduce the treatment burden of frequent anti-vascular endothelial growth factor (anti-VEGF) injections, and improve real-world vision outcomes for patients.
If you want more trading ideas like this one ,đŻ press a thumb up! đ Have a question? Don't be shy to ask! đ€ Interested to study how to analyze charts, follow me!
Informationen och publikationerna Àr inte avsedda att vara, och utgör inte heller finansiella, investerings-, handels- eller andra typer av rÄd eller rekommendationer som tillhandahÄlls eller stöds av TradingView. LÀs mer i AnvÀndarvillkoren.